oxophenylarsine has been researched along with coenzyme q10 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dobrovol's'kyÄ, FV; Miedviediev, OS; Rudyk, OV; Sahach, VF; Shymans'ka, TV; Vavilova, HL | 1 |
1 other study(ies) available for oxophenylarsine and coenzyme q10
Article | Year |
---|---|
[Inhibition of mitochondrial permeability transition pore is one of the mechanisms of cardioprotective effect of coenzyme Q10].
Topics: Animals; Arsenicals; Cardiotonic Agents; Coenzymes; Guinea Pigs; In Vitro Techniques; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Myocardial Contraction; Myocardial Reperfusion Injury; Oxygen Consumption; Ubiquinone | 2007 |